Jean-PierreLindenmayerMD

Clinical Trials

• Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia Start of enrollment: 2004 Oct 01

  Completed

  Phase 4

• High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder Start of enrollment: 2004 Dec 01

  Completed

  Phase 2, Phase 3

• Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder Start of enrollment: 2003 Sep 01

  Completed

  Phase 2, Phase 3

• Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training Start of enrollment: 2006 Sep 01

  Completed

  Not Applicable

• Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder Start of enrollment: 2006 Nov 01

  Completed

  Phase 4

• Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness Start of enrollment: 2006 Sep 01

  Completed

  Not Applicable

• Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia Start of enrollment: 2007 Apr 01

  Unknown status

  Not Applicable

• Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder Start of enrollment: 2008 Feb 01

  Withdrawn

  Phase 2

• Cognitive Skills Training Using Computer for Patients With Severe Mental Illness Start of enrollment: 2003 Feb 01

  Completed

  Phase 4

• Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations Start of enrollment: 2014 Apr 01

  Completed

  Not Applicable

• Can Cognitive Training Decrease Reactive Aggression? Start of enrollment: 2016 Aug 16

  Completed

  Not Applicable

• Join now to see all